Description
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
Product Unit Size | Cost | Quantity | Stock |
---|
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
Cas No. | 1425381-60-7 |
---|---|
Purity | ≥98% |
Formula | C24H28N8O2 |
Formula Wt. | 460.54 |
IUPAC Name | 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile |
Synonym | ASN-002, ASN002 |
Appearance | Yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Montilla A, Gomez-Garcia F, Gomez-Arias P, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol The (Heidelb). 2019 Dec;9(4):655-683. PMID: 31606872
Caspase 9 substrate.
Histamine H1 antagonist.
EGFR inhibitor.
Ras inhibitor.
Diterpene found in coffee beans.
BRD2/3/4 inhibitor.
Endogenous APP peptide cleavage product, primar...
Viologen derivative
Induces apoptosis, DNA cleavage and strand brea...
Phenothiazine, FIASMA; D1/2/3/4, 5-HT1/2, M1/2 ...
Viral M2 proton channel blocker, MAO-A, NET, NM...
Synthesis impurity
c-Met inhibitor.
Glutathione-ITC conjugate, antioxidant.
Potential AhR binding agent.
Protein synthesis inhibitor, DPP2 and metallope...
Taxane synthesis intermediate.
Sesquiterpene alcohol found in various essentia...
Flavone found in Teucrium.
Proteasome inhibitor, miR33b modulator.